Hitesh Chemicals And Drugs Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 29-07-2024
- Paid Up Capital ₹ 5.00 M
as on 29-07-2024
- Company Age 39 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.53 Cr
as on 29-07-2024
- Satisfied Charges ₹ 4.45 Cr
as on 29-07-2024
- Revenue 4.51%
(FY 2023)
- Profit -85.59%
(FY 2023)
- Ebitda -48.30%
(FY 2023)
- Net Worth 7.09%
(FY 2023)
- Total Assets -5.43%
(FY 2023)
About Hitesh Chemicals And Drugs
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹4.53 Cr. The company has closed loans amounting to ₹4.45 Cr, as per Ministry of Corporate Affairs (MCA) records.
Suresh Manchanda, Hitesh Manchanda, Aryan Manchanda, and One other member serve as directors at the Company.
- CIN/LLPIN
U24110TG1985PTC005755
- Company No.
005755
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Sep 1985
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
A.P, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Hitesh Chemicals And Drugs?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Suresh Manchanda  | Managing Director | 08-Jan-2003 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Hitesh Manchanda | Whole-Time Director | 08-Jan-2003 | Current |
| Aryan Manchanda | Whole-Time Director | 06-Nov-2021 | Current |
| Neena Manchanda | Whole-Time Director | 08-Jan-2003 | Current |
Financial Performance of Hitesh Chemicals And Drugs.
Hitesh Chemicals And Drugs Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 4.51% increase. The company also saw a substantial fall in profitability, with a 85.59% decrease in profit. The company's net worth moved up by a moderate rise of 7.09%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Hitesh Chemicals And Drugs?
In 2023, Hitesh Chemicals And Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 28 Oct 2021 | ₹4.00 M | Open |
Others Creation Date: 29 Jun 2018 | ₹4.13 Cr | Open |
Centuriam Bank Limited Creation Date: 09 Mar 2004 | ₹0.30 M | Satisfied |
How Many Employees Work at Hitesh Chemicals And Drugs?
Unlock and access historical data on people associated with Hitesh Chemicals And Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hitesh Chemicals And Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hitesh Chemicals And Drugs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
